Mental health institutions are set to benefit from the manufacturing of carbamazepine drugs which were in critical shortage after a local pharmaceutical company started manufacturing it.
It emerged during a tour of Bulawayo companies by Industry and Commerce Deputy Minister Mr Raj Modi that Datlabs will now be manufacturing one of the main drugs needed by mental health institutions.
The company’s Chief Executive Officer Mr Todd Moyo said mental health institutions will start receiving these pills from next week.
We were asked to do a special run for our mental patients. We have finished them we are now packing them and we doing our final tests now… we should have them out by Friday,” said Mr Moyo.
He, however, highlighted that foreign currency challenges are limiting production levels, adding that resuscitation of the large volume parentals factory would see it manufacture intravenous fluids ‘drips” (lvps) as they have a capacity to produce 1,8 million units a year.
The firm also committed to uphold government’s directive that no drugs should be sold in foreign currency and prices must be affordable for patients.